<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>108(9)</volume><submitter>Baker SG</submitter><pubmed_abstract>The subpopulation treatment effect pattern plot (STEPP) is an appealing method for assessing the clinical impact of a predictive marker on patient outcomes and identifying a promising subgroup for further study. However, its original formulation lacked a decision analytic justification and applied only to a single marker. We derive a decision-analytic result that motivates STEPP. We discuss the incorporation of multiple predictive markers into STEPP using risk difference, cadit, and responders-only benefit functions. Applying STEPP to data from a breast cancer treatment trial with multiple markers, we found that none of the three benefit functions identified a promising subgroup for further study. Applying STEPP to hypothetical data from a trial with 100 markers, we found that all three be</pubmed_abstract><journal>Journal of the National Cancer Institute</journal><pagination>djw101</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5939825</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluating Markers for Guiding Treatment.</pubmed_title><pmcid>PMC5939825</pmcid><pubmed_authors>Bonetti M</pubmed_authors><pubmed_authors>Baker SG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluating Markers for Guiding Treatment.</name><description>The subpopulation treatment effect pattern plot (STEPP) is an appealing method for assessing the clinical impact of a predictive marker on patient outcomes and identifying a promising subgroup for further study. However, its original formulation lacked a decision analytic justification and applied only to a single marker. We derive a decision-analytic result that motivates STEPP. We discuss the incorporation of multiple predictive markers into STEPP using risk difference, cadit, and responders-only benefit functions. Applying STEPP to data from a breast cancer treatment trial with multiple markers, we found that none of the three benefit functions identified a promising subgroup for further study. Applying STEPP to hypothetical data from a trial with 100 markers, we found that all three be</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Sep</publication><modification>2025-04-22T01:39:32.867Z</modification><creation>2019-03-26T23:47:29Z</creation></dates><accession>S-EPMC5939825</accession><cross_references><pubmed>27193772</pubmed><doi>10.1093/jnci/djw101</doi></cross_references></HashMap>